Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-28

FDA Approved: VALACYCLOVIR — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)

View source ↗

Summary

The FDA approved a supplemental application for valacyclovir from Sun Pharmaceutical Industries, Inc., resulting in changes to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valacyclovir (Valacyclovir)

Snippet

SUPPL AP for VALACYCLOVIR (VALACYCLOVIR)